Target intelligence / Profile preview

Fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1)

Target
FAHD1
Molecular classification
Enzyme (oxaloacetate decarboxylase), Hydrolase (acylpyruvate hydrolase), Fumarylacetoacetate hydrolase superfamily
01

Overview

Fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) is a 24-kDa mitochondrial enzyme encoded by the FAHD1 gene. It belongs to the fumarylacetoacetate hydrolase superfamily and displays bifunctional enzymatic activities: oxaloacetate decarboxylase (ODx), which catalyzes the conversion of oxaloacetate (OAA) to pyruvate and CO₂, and acylpyruvate hydrolase (ApH), which hydrolyzes acetylpyruvate and fumarylpyruvate[1][3][6][9]. FAHD1 is a key regulator of mitochondrial metabolism, modulating cellular energy production by regulating OAA levels, TCA cycle flux, and ROS production, thereby impacting cell proliferation, senescence, and survival[2][5][7]. FAHD1's expression is tissue-dependent (kidney, liver) and is implicated in various pathophysiological states, including cancer and reproductive disorders[5][7]. Its structure consists of a conserved catalytic center shared within the superfamily, with species-specific sequence variability enabling selective antibody recognition and post-translational regulatory modifications[1][9]. If more structural, ligand, or inhibitor information becomes available, FAHD1 may emerge as a direct pharmacological target for diseases related to mitochondrial dysfunction or metabolic imbalance.

Other names
FAHD1C16orf36YISKLOxaloacetate decarboxylaseAcylpyruvase FAHD1Fumarylacetoacetate hydrolase domain-containing protein 1OAA decarboxylaseODxYisK-like proteinFLJ36880 protein
02

Mechanism of action

For in-development therapeutics, likely inhibition or modulation of FAHD1’s oxaloacetate decarboxylase activity, affecting mitochondrial OAA levels, TCA cycle flux, and ROS production

03

Biological functions

Mitochondrial metabolismRegulation of TCA cycle fluxCellular energy homeostasisMetabolic homeostasisSenescence regulationOxaloacetate tautomerizationReduction of mitochondrial reactive oxygen species (ROS)
04

Disease associations

Cancer (e.g., osteosarcoma)Mitochondrial dysfunctionPremature ovarian failureSpermatogenic failureMetabolic disorders
05

Safety considerations

Targeting mitochondrial metabolic enzymes entails potential risks for off-target metabolic disturbances, impaired ATP production, and altered ROS signaling; full safety profile is not established
06

Interacting drugs

None currently known or approved; research in therapeutics is ongoing but no specific interacting drugs are identified in the current literature
07

Biomarkers

Post-translational modifications such as SIRT3-mediated acetylation (e.g., K83 site)Expression changes in disease states

Beyond the preview

Go deeper on Fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call